Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOral Presentations - Physicians/Scientists/Pharmacists

Early reduction of FDG uptake predicts pathologic tumor response to preoperative radio-chemotherapy in locally advanced rectal cancer

Giuseppe Lucio Cascini, Antonio Avallone, Luigi Aloj, Paolo Delrio, Cesare Guida, Fabiana Tatangelo, Francesco De Martinis, Pasquale Comella, Valerio Parisi and Secondo Lastoria
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 45P;
Giuseppe Lucio Cascini
1Nuclear Medicine, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Avallone
2Medical Oncology A, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luigi Aloj
1Nuclear Medicine, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Delrio
3Surgical Oncology C, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cesare Guida
4Radiotherapy, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiana Tatangelo
5Pathology, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco De Martinis
1Nuclear Medicine, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pasquale Comella
2Medical Oncology A, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerio Parisi
3Surgical Oncology C, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Secondo Lastoria
1Nuclear Medicine, INT Napoli, Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

131

Objectives: Monitoring of FDG uptake is useful for assessing the effects of chemo and/or radiotherapy. Aim of this study is to correlate the standardized uptake value (SUV) changes during and after preoperative radio-chemotherapy, with pathologic response in locally advanced rectal cancer (LARC) patients.

Methods: We are evaluating patients with LARC undergoing neoadjuvant radio-chemotherapy (three cycles of oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid during pelvic radiotherapy with 45 Gy) prior to total mesorectal excision. Patients are staged using endoscopic ultrasound, magnetic resonance imaging and computed tomography. FDG-PET is performed at baseline for staging purposes and repeated 12 days after the beginning of radio-chemotherapy (intermediate scan) and prior to surgery. SUV changes within the primary tumor are monitored by ROI analysis of the studies. Percentage of SUV decrease from baseline to intermediate (early change) and from baseline to presurgical scan (overall change) are being assessed and correlated with pathologic response classified as tumor regression grade (TRG). We have completed the analysis on thirty three patients.

Results: Eighteen tumors (55%) showed complete (TRG1) or subtotal (TRG2) pathological regression and were classified as responders, whereas 15 cases (45%, showing TRG3 or TRG4) were considered non-responders. The early median decrease of tumor SUV significantly differed between responders (-62%) and non-responders (-22%). A significant correlation was also found between TRGs and early SUV changes (p<.0001). Responders were correctly identified by an early decrease of SUV-mean ≥ 52%.

Conclusions: This study shows that FDG-PET performed early during the course of neoadjuvant radio-chemotherapy can predict pathologic response to treatment. These findings support the use of FDG-PET during LARC as a prognostic tool to aid in surgical and medical treatment decision making.

Embedded Image

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 47, Issue suppl 1
May 1, 2006
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Early reduction of FDG uptake predicts pathologic tumor response to preoperative radio-chemotherapy in locally advanced rectal cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Early reduction of FDG uptake predicts pathologic tumor response to preoperative radio-chemotherapy in locally advanced rectal cancer
Giuseppe Lucio Cascini, Antonio Avallone, Luigi Aloj, Paolo Delrio, Cesare Guida, Fabiana Tatangelo, Francesco De Martinis, Pasquale Comella, Valerio Parisi, Secondo Lastoria
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 45P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Early reduction of FDG uptake predicts pathologic tumor response to preoperative radio-chemotherapy in locally advanced rectal cancer
Giuseppe Lucio Cascini, Antonio Avallone, Luigi Aloj, Paolo Delrio, Cesare Guida, Fabiana Tatangelo, Francesco De Martinis, Pasquale Comella, Valerio Parisi, Secondo Lastoria
Journal of Nuclear Medicine May 2006, 47 (suppl 1) 45P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oral Presentations - Physicians/Scientists/Pharmacists

  • Early stage assessment of intrabronchial valve placement by Xe ventilation/Tc MAA perfusion scintigraphy in patients with severe emphysema
  • Diagnosis ability of dual-phase F-18-fluoro-2-deoxy-D-glucose SPECT/PET for distinguishing the benign and malignant lesions
  • Accuracy of 18F-FDG-PET/CT in the detection of malignant ovarian lesions: Correlation with ultrasound and histopathological findings
Show more Oral Presentations - Physicians/Scientists/Pharmacists

Oncology Track

  • Early stage assessment of intrabronchial valve placement by Xe ventilation/Tc MAA perfusion scintigraphy in patients with severe emphysema
  • Diagnosis ability of dual-phase F-18-fluoro-2-deoxy-D-glucose SPECT/PET for distinguishing the benign and malignant lesions
  • Accuracy of 18F-FDG-PET/CT in the detection of malignant ovarian lesions: Correlation with ultrasound and histopathological findings
Show more Oncology Track

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire